Inovio Pharmaceuticals (INO) Price to Sales (2011 - 2025)
Inovio Pharmaceuticals' (INO) Price to Sales came in at 1248.52 for Q4 2025, up 447.0% from 228.26 a year earlier and up 81.6% from the prior quarter.
Powered by 
Analysis
Inovio Pharmaceuticals (INO) Price to Sales (2011 - 2025) Analysis & Trends
Since Q1 2011, Inovio Pharmaceuticals has reported Price to Sales for 60 quarters.
- Annual Price to Sales has increased for three consecutive years.
- In prior years, Inovio Pharmaceuticals' Price to Sales was 228.26 in FY2024 (+36.1%), 167.66 in FY2023 (+335.8%), 38.47 in FY2022 (-93.7%) and 611.18 in FY2021 (+229.9%).
- The Q4 2025 figure stands as the highest quarterly Price to Sales since Q2 2020.
- On a year-over-year basis, Price to Sales increased in four of the last six quarters, with growth averaging 155.9%.
- The strongest year-over-year quarter for Price to Sales in the past five years was Q3 2024, with growth of 494.9%; the weakest was Q1 2023, with a decline of 95.9%.
- According to Business Quant data, Price to Sales for the three prior quarters was 687.51 (Q3 2025), 434.43 (Q2 2025) and 211.16 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Inovio Pharmaceuticals | 94.68 Mn | 94.68 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1,248.52 |
| Sep 30, 2025 | 687.51 |
| Jun 30, 2025 | 434.43 |
| Mar 31, 2025 | 211.16 |
| Dec 31, 2024 | 228.26 |
| Sep 30, 2024 | 741.63 |
| Jun 30, 2024 | 354.46 |
| Mar 31, 2024 | 501.54 |
| Dec 31, 2023 | 167.66 |
| Sep 30, 2023 | 124.66 |
| Jun 30, 2023 | 12.54 |
| Mar 31, 2023 | 21.17 |
| Dec 31, 2022 | 38.47 |
| Sep 30, 2022 | 39.32 |
| Jun 30, 2022 | 204.06 |
| Mar 31, 2022 | 513.02 |
| Dec 31, 2021 | 611.18 |
| Sep 30, 2021 | 231.16 |
| Jun 30, 2021 | 301.81 |
| Mar 31, 2021 | 301.03 |
API Access
Inovio Pharmaceuticals Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=INO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "INO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=INO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();